Related Experiment Video
Updated: Jan 23, 2026

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
Published on: November 30, 2022
Linking FHIR-Based Medication Data to a Computable Algorithm for Heart Medication Optimization: A Critical Component
Joey LeGrand1, Mohamed S Ali2, Allen Flynn3
1CodeRx Nashville Tennessee USA.
Insights
SmartHF enhances guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) by integrating Fast Healthcare Interoperability Resources (FHIR) medication data with clinical algorithms. This system improves adherence and care quality by overcoming data integration challenges.
Area of Science:
- Cardiology
- Health Informatics
- Clinical Decision Support
Background:
- Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) has proven efficacy, yet consistent application remains a challenge.
- Electronic health records (EHR) offer a potential solution for optimizing GDMT delivery.
- Bridging the gap between EHR data and clinical algorithms is crucial for improving patient outcomes.
Purpose of the Study:
- To develop and evaluate SmartHF, a clinical decision support system.
- To enhance adherence to GDMT for HFrEF through improved medication management.
- To demonstrate the feasibility of integrating Fast Healthcare Interoperability Resources (FHIR)-based medication data with clinical algorithms.
Main Methods:
- Developed SmartHF, a system linking FHIR-based medication data with clinical algorithms for HFrEF management.
- Utilized CodeRx platform for mapping medication products to ingredients via RxNorm.
- Addressed challenges in interpreting structured and unstructured medication instructions, focusing on data granularity for precise ingredient identification.
Main Results:
- SmartHF successfully processed FHIR MedicationRequest data resources.
- The system accurately converted free-text dosing instructions into usable formats.
- Validated functionality with real and synthetic patient data, including handling edge cases like non-standard products and missing dose information.
Conclusions:
- FHIR-based medication data integration holds significant potential for enhancing clinical decision support tools.
- SmartHF demonstrates a viable approach to improving care quality in HFrEF management.
- The study highlights key challenges and solutions in integrating diverse medication data for clinical applications.
Introduction:
Despite strong evidence supporting guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF), a significant gap persists in the consistent application of these therapies. This shortfall has prompted organizations like the American College of Cardiology to recommend leveraging electronic health records (EHR) to optimize GDMT. This paper discusses the development of SmartHF, a clinical decision support system designed to enhance therapy adherence by effectively linking Fast Healthcare Interoperability Resources (FHIR)-based medication data with clinical algorithms tailored for the management of HFrEF.
Methods:
The SmartHF system integrates FHIR-based medication data with clinical algorithms through a multi-step approach. Central to this process is data from CodeRx, a platform that utilizes streamlined data pipelines to map medication products to their ingredients using RxNorm. The methodology addresses the challenge of interpreting both structured and unstructured medication instructions, ensuring a precise linkage of product identifiers to algorithm-relevant ingredients and their corresponding strengths. Specific attention is given to the data granularity needed for distinguishing precise ingredients within complex formulations, such as sacubitril/valsartan and metoprolol salt form variants.
Results:
The deployment of SmartHF involved rigorous testing using actual and synthetic patient datasets to validate its functionality. Results demonstrated the system's ability to process FHIR MedicationRequest data resources accurately, convert free-text dosing instructions into usable formats, and handle edge cases, including non-standard products and missing dose information.
Conclusions:
This article describes the potential of FHIR-based medication data integration for enhancing clinical decision support tools and improving care quality. It highlights the challenges and solutions for this integration.
Related Concept Videos
Heart Failure V: Medical Management
Inhaled Medications
Rheumatic Heart Disease III: Medical Management
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis III: Medical Management

